Cellegy regulatory affairs staff changes
Executive Summary
Cellegy announces resignation of Senior VP-Medical and Regulatory Affairs Daniel Azarnoff, MD, and VP-Regulatory Affairs and Quality William Schary, MD, Aug. 14. The company will engage the law firm of Hyman, Phelps & McNamara to manage FDA regulatory concerns. New arrangement follows a recent FDA "not approvable" letter for Fortigel (1"The Pink Sheet" July 14, 2003, In Brief)...